A patient with systemic lupus erythematosus (SLE) presents with increased fatigue, joint swelling, frothy urine, and shortness of breath. Laboratory findings indicate significant proteinuria and elevated creatinine levels, while a chest X-ray reveals bilateral pleural effusions. What is the priority nursing intervention to address the patient's current condition?

B) Monitor the patient's respiratory status and oxygen saturation closely.

A) Educate the patient about reducing sodium intake to manage edema.

B) Monitor the patient's respiratory status and oxygen saturation closely.

C) Encourage the patient to maintain a high-protein diet to offset proteinuria.

D) Administer prescribed cyclophosphamide and prednisone as ordered.

A patient with systemic lupus erythematosus (SLE) presents with increased fatigue, joint swelling, low-grade fever, new-onset edema, and frothy urine. A urinalysis reveals significant proteinuria and blood tests show elevated creatinine levels. Which nursing intervention is most appropriate to prioritize for this patient?

B) Monitor daily weights and assess for signs of fluid overload.

A) Encourage the patient to increase fluid intake to flush out the kidneys.

B) Monitor daily weights and assess for signs of fluid overload.

C) Advise the patient to reduce physical activity to conserve energy.

D) Educate the patient on reducing sodium intake to manage joint swelling.

A patient on high-dose prednisone therapy for autoimmune disease management reports a persistent sore throat and decreased appetite. Based on this case study, which nursing action is the most appropriate?

B) Assess the patient for additional signs of infection and notify the healthcare provider.

A) Advise the patient to increase fluid intake and monitor symptoms for 48 hours.

B) Assess the patient for additional signs of infection and notify the healthcare provider.

C) Reassure the patient that these symptoms are common side effects of prednisone therapy.

D) Suggest the patient take over-the-counter pain relief for the sore throat and continue monitoring.

A patient with lupus nephritis is being treated with high-dose prednisone and intravenous cyclophosphamide. Which nursing intervention is most important to implement to prevent treatment-related complications?

B) Monitor the patient for signs of infection, such as fever and increased cough.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Monitor the patient for signs of infection, such as fever and increased cough.

C) Educate the patient about the importance of a low-sodium diet to manage hypertension.

D) Assist the patient in performing range-of-motion exercises to reduce joint stiffness.

A patient with systemic lupus erythematosus (SLE) on cyclophosphamide and prednisone presents with new onset palpitations, shortness of breath, and irregular heart rate. An ECG shows premature ventricular contractions (PVCs). Considering her current treatment and symptoms, which of the following nursing interventions is most appropriate to prioritize?

C) Monitor the patient closely for signs of infection and report any fever or increased white blood cell count

A) Administer supplemental oxygen to maintain oxygen saturation above 92%

B) Educate the patient on the importance of medication adherence to prevent renal complications

C) Monitor the patient closely for signs of infection and report any fever or increased white blood cell count

D) Encourage the patient to increase fluid intake to support renal function

A patient with lupus is being treated with cyclophosphamide and prednisone. She is experiencing intermittent palpitations, shortness of breath on exertion, and irregular heartbeats with occasional skipped beats. An ECG shows premature ventricular contractions (PVCs), and her oxygen saturation drops to 92% on exertion. Considering these symptoms, which is the most appropriate nursing action to prioritize?

B) Monitor the patient’s cardiac rhythm and report any significant changes to the healthcare provider.

A) Encourage increased fluid intake to improve circulation.

B) Monitor the patient’s cardiac rhythm and report any significant changes to the healthcare provider.

C) Instruct the patient to perform deep breathing exercises to increase oxygenation.

D) Advise the patient to limit physical activity to prevent exacerbation of symptoms.

A patient with systemic lupus erythematosus (SLE) has been diagnosed with lupus-induced myocarditis and a low-grade infection with Staphylococcus epidermidis. Which nursing intervention is most important to prioritize in this patient's care plan?

A) Monitor the patient's cardiac rhythm and report any significant changes.

B) Administer immunosuppressive therapy to control the SLE symptoms.

C) Encourage increased fluid intake to promote renal function.

D) Educate the patient on the importance of completing the full course of antibiotics.

A patient with systemic lupus erythematosus is diagnosed with lupus-induced myocarditis and a low-grade Staphylococcus epidermidis infection. The healthcare team is adjusting her treatment plan. Which nursing intervention is most critical to prioritize in this scenario?

A) Monitoring the patient's heart rate and rhythm closely while administering low-dose beta-blockers.

B) Encouraging the patient to increase fluid intake to help flush out the infection.

C) Administering immunosuppressive medication to control lupus symptoms despite the presence of infection.

D) Educating the patient on the importance of adhering to a low-sodium diet to manage cardiac symptoms.

A patient undergoing treatment for lupus has shown a mixed response to medication adjustments, including the introduction of low-dose beta-blockers and immunosuppressants. The patient reports increased fatigue and muscle tenderness, with laboratory results indicating elevated creatine kinase (CK) levels. Considering these symptoms and lab findings, which nursing intervention is most appropriate to address the patient's current condition?

D) Administer prescribed corticosteroids and monitor for side effects.

A) Encourage increased fluid intake to prevent renal complications.

B) Monitor for signs of infection and report any new symptoms immediately.

C) Educate the patient on the importance of gradual activity to prevent muscle strain.

D) Administer prescribed corticosteroids and monitor for side effects.

A patient with lupus is being treated with low-dose beta-blockers and has developed increased fatigue and muscle tenderness. Laboratory tests show elevated creatine kinase levels and a mild increase in serum creatinine. Which nursing intervention should be prioritized to address the patient's current condition?

A) Administer prescribed corticosteroids to reduce inflammation.

B) Encourage increased fluid intake to support renal function.

C) Educate the patient about pacing activities to manage fatigue.

D) Monitor the patient's ECG for changes in heart rhythm.

Systemic Lupus Erythematosus - Nursing Case Study

Pathophysiology

• Primary mechanism: Systemic Lupus Erythematosus (SLE) is characterized by the production of autoantibodies against nuclear antigens, leading to immune complex formation. These complexes deposit in tissues, triggering inflammation and tissue damage, especially in skin, joints, kidneys, and the central nervous system.

• Secondary mechanism: A dysregulated immune response, including hyperactive B and T lymphocytes, further exacerbates the production of autoantibodies and promotes chronic inflammation, contributing to the multisystem involvement seen in SLE.

• Key complication: Persistent immune complex deposition and inflammation can lead to irreversible organ damage, with lupus nephritis being a significant concern, potentially resulting in kidney failure if not managed effectively.

Patient Profile

Demographics:

32-year-old female, school teacher

History:

• Key past medical history: Diagnosed with Systemic Lupus Erythematosus 3 years ago, history of mild Raynaud's phenomenon

• Current medications: Hydroxychloroquine 200 mg daily, Prednisone 10 mg daily, Ibuprofen 400 mg as needed for pain

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing joint pain and fatigue

• Key symptoms: Swollen and painful joints, facial rash, intermittent low-grade fever, mild shortness of breath

• Vital signs: Blood pressure 138/88 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 100.4°F (38°C), oxygen saturation 94% on room air

Section 1

New Complications:

During a follow-up visit, the patient reports worsening of her symptoms, including increased fatigue, more pronounced joint swelling, and persistent low-grade fever. Notably, she has developed new-onset edema in her lower extremities and reports experiencing frothy urine, raising concerns about possible lupus nephritis. A urinalysis is ordered and reveals significant proteinuria with a protein level of 3.5 g/dL, along with the presence of red blood cell casts, suggesting renal involvement. Blood tests show elevated creatinine levels at 1.8 mg/dL, indicating a decline in renal function. These findings prompt the healthcare team to consider a renal biopsy to confirm the diagnosis and assess the extent of kidney damage.

In addition to renal complications, the patient's shortness of breath has progressively worsened. A chest X-ray is performed and reveals bilateral pleural effusions. The pleural fluid analysis shows an exudative fluid with elevated lactate dehydrogenase (LDH) and low glucose levels, consistent with pleuritis secondary to SLE. The combination of joint pain, renal involvement, and pleural effusions indicates a significant flare of her systemic lupus erythematosus, necessitating a reassessment of her current treatment regimen.

Given the patient's deteriorating condition, the healthcare team discusses the need for more aggressive immunosuppressive therapy to control the active inflammation and prevent further organ damage. The rheumatologist recommends initiating intravenous cyclophosphamide and increasing the dosage of prednisone to manage the acute exacerbation. Close monitoring of renal function, respiratory status, and overall response to treatment will be crucial in guiding further management decisions and preventing long-term complications.

Section 2

Response to Interventions:

Following the initiation of intravenous cyclophosphamide and an increased dosage of prednisone, the patient is closely monitored for both therapeutic response and potential side effects. Over the first few days, she reports a slight decrease in joint pain and stabilization of her fevers, though fatigue remains a significant concern. Her vital signs show a stable blood pressure of 125/80 mmHg, heart rate of 88 beats per minute, respiratory rate of 20 breaths per minute, and oxygen saturation of 95% on room air.

Laboratory tests repeated on day three of treatment reveal a modest improvement in renal function, with creatinine levels decreasing to 1.6 mg/dL. However, urinalysis continues to show significant proteinuria, albeit with a slight reduction to 3.2 g/dL. The patient's pleuritic symptoms have not fully resolved, and a repeat chest X-ray shows persistent, though slightly reduced, pleural effusions. These mixed findings suggest a partial response to the current treatment regimen, but also indicate the need for continued vigilance.

Despite these improvements, the healthcare team remains concerned about the risk of new complications, particularly given the high-dose steroid therapy. The patient is educated about the importance of monitoring for signs of infection, such as increased cough, fever, or any new symptoms, and the team remains prepared to adjust the treatment plan as necessary. The decision is made to continue current therapies while planning for a follow-up renal biopsy to further assess kidney involvement and guide long-term management. The focus remains on balancing aggressive disease control with the minimization of treatment-related adverse effects, ensuring the patient is supported through this challenging phase of her illness.

Section 3

A week into the treatment, the patient begins to experience new symptoms, prompting concern from the healthcare team. She reports intermittent episodes of palpitations and shortness of breath, particularly during exertion. On physical examination, her heart rate is found to be irregular, with occasional skipped beats. An electrocardiogram (ECG) is performed, revealing premature ventricular contractions (PVCs), which are new findings for this patient. Additionally, her blood pressure has become slightly elevated, now reading at 138/85 mmHg, and her oxygen saturation occasionally drops to 92% on room air during periods of exertion.

Recent laboratory tests show an increase in her white blood cell count to 12,000/mm³, raising suspicion for an underlying infection, which is a known risk due to the immunosuppressive effects of cyclophosphamide and prednisone. Despite the initial improvement in renal function, the creatinine level has plateaued, and proteinuria remains significant, suggesting persistent renal involvement. These developments, coupled with the new cardiac irregularities, suggest a potential systemic response to treatment and highlight the need for a thorough investigation to rule out myocarditis or other lupus-related cardiac issues.

The healthcare team decides to initiate additional diagnostic testing, including a cardiac MRI to assess for possible lupus-induced myocarditis and blood cultures to rule out infection. Given the complexity of the patient's condition and the potential for multiple overlapping complications, careful coordination between the rheumatology and cardiology teams is essential. The goal is to adjust her treatment plan to address these new developments while maintaining control over her lupus symptoms and minimizing further complications. This balanced approach is crucial to her long-term prognosis and quality of life.

Section 4

New Diagnostic Results:

Following the decision to conduct additional diagnostic testing, the cardiac MRI results reveal mild diffuse myocardial inflammation consistent with lupus-induced myocarditis. This finding corroborates the patient's recent symptoms of palpitations and shortness of breath, as well as the irregular heartbeats detected on the ECG. The presence of myocarditis necessitates a reassessment of her current medication regimen, particularly the balance between immunosuppressive therapy to control the systemic lupus erythematosus and the need to protect her cardiac function.

Concurrently, blood cultures return positive for a low-grade infection, specifically identifying Staphylococcus epidermidis, which is often associated with skin flora but can lead to opportunistic infections, particularly in immunocompromised patients. This finding explains the elevated white blood cell count and suggests that the patient might be experiencing an infection secondary to her immunosuppressive treatment. The healthcare team must now navigate the complexities of treating the infection while managing the lupus and myocarditis, recognizing the potential for drug interactions and further immune suppression.

In light of these diagnostic findings, the rheumatology and cardiology teams, in collaboration with infectious disease specialists, decide to adjust the patient's treatment plan. The introduction of low-dose beta-blockers is considered to manage the heart rhythm irregularities, while antibiotics are initiated to address the infection. The goal is to stabilize her cardiac status and eliminate the infection without exacerbating her lupus symptoms. The team will closely monitor her renal function, cardiac status, and infection markers, anticipating that a coordinated and dynamic treatment approach will help steer the patient back towards a more stable condition. As her journey continues, the focus remains on fine-tuning her treatment to prevent further complications and promote recovery.

Section 5

Change in Patient Status

Over the next 48 hours, the patient exhibits a mixed response to the new treatment regimen. Her palpitations and irregular heartbeats show a modest improvement with the initiation of low-dose beta-blockers, reflected in more stable heart rhythms on subsequent ECGs. However, the patient begins to complain of increased fatigue and generalized muscle tenderness. Vital signs reveal a persistent low-grade fever of 100.4°F, blood pressure at 110/70 mmHg, heart rate at 88 beats per minute, and respiratory rate of 18 breaths per minute. While her oxygen saturation remains stable at 96% on room air, her complaints of fatigue and muscle pain warrant further investigation.

Laboratory results indicate a mild elevation in her creatine kinase (CK) levels, suggesting possible muscle involvement, which raises the suspicion of lupus myositis as a new complication. Additionally, her renal function is closely monitored, with serum creatinine levels creeping up to 1.4 mg/dL from a baseline of 1.1 mg/dL, indicating potential renal involvement or drug-related nephrotoxicity. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) remain elevated, consistent with ongoing inflammation.

The healthcare team recognizes the need to fine-tune her medication regimen to address these new developments. The decision is made to adjust her immunosuppressive therapy, considering the potential for drug-induced side effects versus the benefits of controlling systemic inflammation. The team deliberates introducing a corticosteroid taper to manage the myositis while maintaining antibiotic coverage for the infection. This strategy aims to alleviate her new symptoms without compromising her immune system further, thus preventing additional complications. Close monitoring of her renal function, muscle enzymes, and inflammatory markers will be essential to evaluate the effectiveness of these interventions and guide further adjustments in her treatment plan.